These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27994392)

  • 1. Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.
    Al-Jumaian N; Malik R; Khandekar R; Al-Humaidan A; Al-Madany R; Al-Qahtani R; Altowairqi A; Al-Theeb A; Zaman B; Al-Djasim L; Craven ER; Edward DP
    Middle East Afr J Ophthalmol; 2016; 23(4):296-301. PubMed ID: 27994392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic versus brand-name North American topical glaucoma drops.
    Mammo ZN; Flanagan JG; James DF; Trope GE
    Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.
    Dave P; Villarreal G; Friedman DS; Kahook MY; Ramulu PY
    Ophthalmology; 2015 Dec; 122(12):2373-9. PubMed ID: 26260280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy.
    Marando CM; Seibold LK; SooHoo JR; Pantcheva MB; Ramulu PY; Kahook MY
    Ophthalmology; 2015 Dec; 122(12):2577-8. PubMed ID: 26077575
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic glaucoma drop bottle cap colours.
    Hallaji NAE; Trope GE
    Can J Ophthalmol; 2016 Oct; 51(5):392-393. PubMed ID: 27769334
    [No Abstract]   [Full Text] [Related]  

  • 6. Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles.
    Moore DB; Hammer JD; Akhtari R; Beck J; Sanders S; Kryscio RJ
    J Glaucoma; 2016 Sep; 25(9):780-4. PubMed ID: 27552516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physical properties of generic latanoprost ophthalmic solutions are not identical.
    Kolko M; Koch Jensen P
    Acta Ophthalmol; 2017 Jun; 95(4):370-373. PubMed ID: 28229536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An objective evaluation of eyedrop instillation in patients with glaucoma.
    Stone JL; Robin AL; Novack GD; Covert DW; Cagle GD
    Arch Ophthalmol; 2009 Jun; 127(6):732-6. PubMed ID: 19506189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
    Gaynes BI; Singa RM; Cao Y
    J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An objective assessment of the variability in number of drops per bottle of glaucoma medication.
    Moore DB; Beck J; Kryscio RJ
    BMC Ophthalmol; 2017 May; 17(1):78. PubMed ID: 28532424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations.
    Angmo D; Wadhwani M; Velpandian T; Kotnal A; Sihota R; Dada T
    Int Ophthalmol; 2017 Apr; 37(2):423-428. PubMed ID: 27334605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservative content in generic and brand name glaucoma eye drops.
    Hallaji NA; Rao PP; Trope GE
    Can J Ophthalmol; 2016 Dec; 51(6):492. PubMed ID: 27938964
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
    Queen JH; Feldman RM; Lee DA
    Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry.
    Kahook MY; Fechtner RD; Katz LJ; Noecker RJ; Ammar DA
    Curr Eye Res; 2012 Feb; 37(2):101-8. PubMed ID: 22040280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Force requirements in topical medicine use--the squeezability factor.
    Connor AJ; Severn PS
    Eye (Lond); 2011 Apr; 25(4):466-9. PubMed ID: 21293499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirror-hat device as a drop delivery aid: a pilot study.
    Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
    Can J Ophthalmol; 2014 Aug; 49(4):333-8. PubMed ID: 25103649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black eye drop bottle tips improve compliance.
    Stack RR; McKellar MJ
    Clin Exp Ophthalmol; 2004 Feb; 32(1):39-41. PubMed ID: 14746589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.